Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine

SARS-CoV-2 mRNA vaccines have demonstrated high efficacy and immunogenicity, but limited information is currently available on memory B cell generation and long-term persistence. Here, we investigated spike-specific memory B cells and humoral responses in 145 subjects, up to 6 months after the BNT16...

Full description

Bibliographic Details
Main Authors: Annalisa Ciabattini, Gabiria Pastore, Fabio Fiorino, Jacopo Polvere, Simone Lucchesi, Elena Pettini, Stefano Auddino, Ilaria Rancan, Miriam Durante, Michele Miscia, Barbara Rossetti, Massimiliano Fabbiani, Francesca Montagnani, Donata Medaglini
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
vaccination
SARS-CoV-2
COVID-19
BNT162b2 vaccine
memory B cells
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.740708/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.740708/full

Similar Items